Jun 15, 2026 03:02AM
Jun 14, 2026 04:30PM
Jun 14, 2026 04:30PM
Jun 14, 2026 02:45PM
Jun 11, 2026 05:10AM
Jun 2, 2026 04:05PM
Jun 2, 2026 04:05PM Crinetics and Leading Patient Groups Launch ‘Everyday Advocacy’ Initiative to Empower People Across Endocrine Disease Communities
Jun 2, 2026 04:55AM
May 22, 2026 04:05PM
May 7, 2026 04:05PM
Apr 27, 2026 05:15PM
Apr 27, 2026 05:13PM
Apr 8, 2026 04:05PM
Mar 26, 2026 04:07PM Crinetics submits marketing application for Palsonify in Brazil
Mar 26, 2026 04:05PM
Feb 26, 2026 04:05PM
Feb 5, 2026 04:05PM
Jan 26, 2026 05:00PM
Jan 22, 2026 04:05PM
Jan 22, 2026 04:05PM
Jan 12, 2026 04:05PM Crinetics Pharmaceuticals Announces January 2026 Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Jan 6, 2026 09:23PM
Jan 6, 2026 09:22PM
Jan 5, 2026 04:02PM
Jan 5, 2026 04:02PM
Jan 5, 2026 08:00AM
Jan 5, 2026 08:00AM
Jan 4, 2026 04:00PM Crinetics to announce atumelnant trial results and PALSONIFY update
Jan 4, 2026 04:00PM
Dec 22, 2025 07:06AM
Dec 18, 2025 04:05PM
Dec 11, 2025 04:05PM
Dec 10, 2025 04:34PM
Dec 3, 2025 08:00AM
Dec 3, 2025 08:00AM Crinetics Announces First Patient Dosed in Phase 1/2 Trial Evaluating CRN09682 for the Treatment of Neuroendocrine Tumors and Other Somatostatin Receptor 2-Expressing Tumors
Nov 20, 2025 04:05PM
Nov 20, 2025 04:05PM
Nov 10, 2025 04:28PM
Nov 6, 2025 04:05PM
Oct 23, 2025 08:00AM
Oct 10, 2025 04:41PM
Oct 6, 2025 04:05PM Crinetics Pharmaceuticals to Report Third Quarter 2025 Financial Results on November 6, 2025
Sep 30, 2025 05:31AM
Sep 29, 2025 07:59AM
Sep 26, 2025 07:02AM
Sep 26, 2025 06:47AM
Sep 25, 2025 05:30PM
Sep 25, 2025 05:30PM
Aug 21, 2025 08:45AM Crinetics receives FDA orphan drug designation for CAH treatment
Aug 21, 2025 08:45AM

323,573 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All